At a glance
- Originator Nonindustrial source
- Class Anti-inflammatories; Antiallergics; Antiplatelets; Small molecules
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 28 Feb 2000 New profile
- 28 Feb 2000 Preclinical development for Thrombosis in Taiwan (Unknown route)